Alpha diversity looks like a credible signal in colorectal cancer, though some caution is still warranted.

Alpha diversity shows a strong literature footprint in colorectal cancer, with substantial central evidence and broader supporting literature.

Proteobacteria looks like a credible signal in colorectal cancer, though some caution is still warranted.

Proteobacteria shows a strong literature footprint in colorectal cancer, with substantial central evidence and broader supporting literature.

Faecalibacterium prausnitzii appears to be a strong and relatively human-grounded signal in ulcerative colitis.

Faecalibacterium prausnitzii shows a strong literature footprint in ulcerative colitis, with substantial central evidence and broader supporting literature.

Alpha diversity looks like a credible signal in inflammatory bowel disease, though some caution is still warranted.

Alpha diversity shows a strong literature footprint in inflammatory bowel disease, with substantial central evidence and broader supporting literature.

Faecalibacterium prausnitzii looks like a credible signal in type 2 diabetes, though some caution is still warranted.

Faecalibacterium prausnitzii shows a strong literature footprint in type 2 diabetes, with substantial central evidence and broader supporting literature.

Prevotella copri appears to be a strong and relatively human-grounded signal in obesity.

Prevotella copri shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Bacteroides fragilis looks like a credible signal in ulcerative colitis, though some caution is still warranted.

Bacteroides fragilis shows a strong literature footprint in ulcerative colitis, with substantial central evidence and broader supporting literature.

Butyrate production looks like a credible signal in obesity, though some caution is still warranted.

Butyrate production shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Butyrate production looks like a credible signal in ulcerative colitis, though some caution is still warranted.

Butyrate production shows a strong literature footprint in ulcerative colitis, with substantial central evidence and broader supporting literature.

Alpha diversity looks like a credible signal in crohn's disease, though some caution is still warranted.

Alpha diversity shows a strong literature footprint in crohn's disease, with substantial central evidence and broader supporting literature.

Alpha diversity looks like a credible signal in type 2 diabetes, though some caution is still warranted.

Alpha diversity shows a strong literature footprint in type 2 diabetes, with substantial central evidence and broader supporting literature.

Alpha diversity has meaningful literature visibility in ulcerative colitis, but the current evidence mix suggests a substantial risk of overclaiming.

Alpha diversity shows a strong literature footprint in ulcerative colitis, with substantial central evidence and broader supporting literature.

Faecalibacterium prausnitzii looks like a credible signal in obesity, though some caution is still warranted.

Faecalibacterium prausnitzii shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Bacteroides fragilis looks like a credible signal in obesity, though some caution is still warranted.

Bacteroides fragilis shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Alpha diversity looks like a credible signal in autism, though some caution is still warranted.

Alpha diversity shows a strong literature footprint in autism, with substantial central evidence and broader supporting literature.

Alpha diversity looks like a credible signal in obesity, though some caution is still warranted.

Alpha diversity shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Butyrate production has meaningful literature visibility in colorectal cancer, but the current evidence mix suggests a substantial risk of overclaiming.

Butyrate production shows a strong literature footprint in colorectal cancer, with substantial central evidence and broader supporting literature.

Proteobacteria has meaningful literature visibility in obesity, but the current evidence mix suggests a substantial risk of overclaiming.

Proteobacteria shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Ruminococcus gnavus looks like a credible signal in ulcerative colitis, though some caution is still warranted.

Ruminococcus gnavus shows a strong literature footprint in ulcerative colitis, with substantial central evidence and broader supporting literature.

Proteobacteria has meaningful literature visibility in ulcerative colitis, but the current evidence mix suggests a substantial risk of overclaiming.

Proteobacteria shows a strong literature footprint in ulcerative colitis, with substantial central evidence and broader supporting literature.

Alpha diversity has meaningful literature visibility in atopic dermatitis, but the current evidence mix suggests a substantial risk of overclaiming.

Alpha diversity shows a strong literature footprint in atopic dermatitis, with substantial central evidence and broader supporting literature.

Bacteroides uniformis looks like a credible signal in obesity, though some caution is still warranted.

Bacteroides uniformis shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Tryptophan metabolism looks like a credible signal in colorectal cancer, though some caution is still warranted.

Tryptophan metabolism shows a strong literature footprint in colorectal cancer, with substantial central evidence and broader supporting literature.

Ruminococcus gnavus looks like a credible signal in crohn's disease, though some caution is still warranted.

Ruminococcus gnavus shows a strong literature footprint in crohn's disease, with substantial central evidence and broader supporting literature.

Bacteroides vulgatus has meaningful literature visibility in ulcerative colitis, but the current evidence mix suggests a substantial risk of overclaiming.

Bacteroides vulgatus shows a strong literature footprint in ulcerative colitis, with substantial central evidence and broader supporting literature.

Eubacterium rectale appears to be a strong and relatively human-grounded signal in obesity.

Eubacterium rectale shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Parabacteroides distasonis looks like a credible signal in obesity, though some caution is still warranted.

Parabacteroides distasonis shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Veillonella appears to be a strong and relatively human-grounded signal in crohn's disease.

Veillonella shows a strong literature footprint in crohn's disease, with substantial central evidence and broader supporting literature.

Dialister appears to be a strong and relatively human-grounded signal in obesity.

Dialister shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Proteobacteria has meaningful literature visibility in crohn's disease, but the current evidence mix suggests a substantial risk of overclaiming.

Proteobacteria shows a strong literature footprint in crohn's disease, with substantial central evidence and broader supporting literature.

Faecalibacterium prausnitzii appears to be a strong and relatively human-grounded signal in crohn's disease.

Faecalibacterium prausnitzii shows a strong literature footprint in crohn's disease, with substantial central evidence and broader supporting literature.

Bacteroides fragilis has meaningful literature visibility in crohn's disease, but the current evidence mix suggests a substantial risk of overclaiming.

Bacteroides fragilis shows a strong literature footprint in crohn's disease, with substantial central evidence and broader supporting literature.

Tryptophan metabolism has meaningful literature visibility in type 2 diabetes, but the current evidence mix suggests a substantial risk of overclaiming.

Tryptophan metabolism shows a strong literature footprint in type 2 diabetes, with substantial central evidence and broader supporting literature.

Proteobacteria has meaningful literature visibility in inflammatory bowel disease, but the current evidence mix suggests a substantial risk of overclaiming.

Proteobacteria shows a strong literature footprint in inflammatory bowel disease, with substantial central evidence and broader supporting literature.

Faecalibacterium appears to be a strong and relatively human-grounded signal in ulcerative colitis.

Faecalibacterium shows a strong literature footprint in ulcerative colitis, with substantial central evidence and broader supporting literature.

Bacteroides fragilis looks like a credible signal in inflammatory bowel disease, though some caution is still warranted.

Bacteroides fragilis shows a strong literature footprint in inflammatory bowel disease, with substantial central evidence and broader supporting literature.

Collinsella aerofaciens appears to be a strong and relatively human-grounded signal in obesity.

Collinsella aerofaciens shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Coprococcus appears to be a strong and relatively human-grounded signal in obesity.

Coprococcus shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Escherichia coli looks like a credible signal in ulcerative colitis, though some caution is still warranted.

Escherichia coli shows a strong literature footprint in ulcerative colitis, with substantial central evidence and broader supporting literature.

Bacteroides vulgatus has meaningful literature visibility in crohn's disease, but the current evidence mix suggests a substantial risk of overclaiming.

Bacteroides vulgatus shows a strong literature footprint in crohn's disease, with substantial central evidence and broader supporting literature.

Blautia appears to be a strong and relatively human-grounded signal in colorectal cancer.

Blautia shows a strong literature footprint in colorectal cancer, with substantial central evidence and broader supporting literature.

Bacteroides fragilis looks like a credible signal in type 2 diabetes, though some caution is still warranted.

Bacteroides fragilis shows a strong literature footprint in type 2 diabetes, with substantial central evidence and broader supporting literature.

Ruminococcus gnavus looks like a credible signal in inflammatory bowel disease, though some caution is still warranted.

Ruminococcus gnavus shows a strong literature footprint in inflammatory bowel disease, with substantial central evidence and broader supporting literature.

Coprococcus appears to be a strong and relatively human-grounded signal in crohn's disease.

Coprococcus shows a strong literature footprint in crohn's disease, with substantial central evidence and broader supporting literature.

Lactobacillus appears to be a strong and relatively human-grounded signal in autism.

Lactobacillus shows a strong literature footprint in autism, with substantial central evidence and broader supporting literature.

Prevotella appears to be a strong and relatively human-grounded signal in obesity.

Prevotella shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Lipopolysaccharide biosynthesis looks like a credible signal in obesity, though some caution is still warranted.

Lipopolysaccharide biosynthesis shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Clostridioides difficile looks like a credible signal in ulcerative colitis, though some caution is still warranted.

Clostridioides difficile shows a strong literature footprint in ulcerative colitis, with substantial central evidence and broader supporting literature.

Eubacterium rectale looks like a credible signal in inflammatory bowel disease, though some caution is still warranted.

Eubacterium rectale shows a strong literature footprint in inflammatory bowel disease, with substantial central evidence and broader supporting literature.

Faecalibacterium looks like a credible signal in obesity, though some caution is still warranted.

Faecalibacterium shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Roseburia looks like a credible signal in ulcerative colitis, though some caution is still warranted.

Roseburia shows a strong literature footprint in ulcerative colitis, with substantial central evidence and broader supporting literature.

Eubacterium hallii looks like a credible signal in obesity, though some caution is still warranted.

Eubacterium hallii shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Escherichia coli looks like a credible signal in colorectal cancer, though some caution is still warranted.

Escherichia coli shows a strong literature footprint in colorectal cancer, with substantial central evidence and broader supporting literature.

Bacteroides uniformis looks like a credible signal in type 2 diabetes, though some caution is still warranted.

Bacteroides uniformis shows a strong literature footprint in type 2 diabetes, with substantial central evidence and broader supporting literature.

Escherichia coli looks like a credible signal in atopic dermatitis, though some caution is still warranted.

Escherichia coli shows a strong literature footprint in atopic dermatitis, with substantial central evidence and broader supporting literature.

Staphylococcus has meaningful literature visibility in colorectal cancer, but the current evidence mix suggests a substantial risk of overclaiming.

Staphylococcus shows a strong literature footprint in colorectal cancer, with substantial central evidence and broader supporting literature.

Alistipes looks like a credible signal in obesity, though some caution is still warranted.

Alistipes shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Richness looks like a credible signal in colorectal cancer, though some caution is still warranted.

Richness shows a strong literature footprint in colorectal cancer, with substantial central evidence and broader supporting literature.

Butyrate production has meaningful literature visibility in crohn's disease, but the current evidence mix suggests a substantial risk of overclaiming.

Butyrate production shows a strong literature footprint in crohn's disease, with substantial central evidence and broader supporting literature.

Ruminococcus torques looks like a credible signal in crohn's disease, though some caution is still warranted.

Ruminococcus torques shows a strong literature footprint in crohn's disease, with substantial central evidence and broader supporting literature.

Veillonella appears to be a strong and relatively human-grounded signal in inflammatory bowel disease.

Veillonella shows a strong literature footprint in inflammatory bowel disease, with substantial central evidence and broader supporting literature.

Faecalibacterium appears to be a strong and relatively human-grounded signal in autism.

Faecalibacterium shows a strong literature footprint in autism, with substantial central evidence and broader supporting literature.

Blautia looks like a credible signal in obesity, though some caution is still warranted.

Blautia shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Butyrate production has meaningful literature visibility in inflammatory bowel disease, but the current evidence mix suggests a substantial risk of overclaiming.

Butyrate production shows a strong literature footprint in inflammatory bowel disease, with substantial central evidence and broader supporting literature.

Bacteroides vulgatus looks like a credible signal in colorectal cancer, though some caution is still warranted.

Bacteroides vulgatus shows a strong literature footprint in colorectal cancer, with substantial central evidence and broader supporting literature.

Anaerostipes hadrus looks like a credible signal in obesity, though some caution is still warranted.

Anaerostipes hadrus shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Streptococcus looks like a credible signal in type 2 diabetes, though some caution is still warranted.

Streptococcus shows a strong literature footprint in type 2 diabetes, with substantial central evidence and broader supporting literature.

Bifidobacterium looks like a credible signal in atopic dermatitis, though some caution is still warranted.

Bifidobacterium shows a strong literature footprint in atopic dermatitis, with substantial central evidence and broader supporting literature.

Veillonella looks like a credible signal in ulcerative colitis, though some caution is still warranted.

Veillonella shows a strong literature footprint in ulcerative colitis, with substantial central evidence and broader supporting literature.

Parabacteroides distasonis looks like a credible signal in type 2 diabetes, though some caution is still warranted.

Parabacteroides distasonis shows a strong literature footprint in type 2 diabetes, with substantial central evidence and broader supporting literature.

Fusobacterium nucleatum looks like a credible signal in colorectal cancer, though some caution is still warranted.

Fusobacterium nucleatum shows a strong literature footprint in colorectal cancer, with substantial central evidence and broader supporting literature.

Bifidobacterium looks like a credible signal in obesity, though some caution is still warranted.

Bifidobacterium shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Butyrate production has meaningful literature visibility in type 2 diabetes, but the current evidence mix suggests a substantial risk of overclaiming.

Butyrate production shows a strong literature footprint in type 2 diabetes, with substantial central evidence and broader supporting literature.

Alistipes looks like a credible signal in type 2 diabetes, though some caution is still warranted.

Alistipes shows a strong literature footprint in type 2 diabetes, with substantial central evidence and broader supporting literature.

Bacteroides vulgatus has meaningful literature visibility in inflammatory bowel disease, but the current evidence mix suggests a substantial risk of overclaiming.

Bacteroides vulgatus shows a strong literature footprint in inflammatory bowel disease, with substantial central evidence and broader supporting literature.

Acetate production has meaningful literature visibility in obesity, but the current evidence mix suggests a substantial risk of overclaiming.

Acetate production shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Eubacterium hallii looks like a credible signal in inflammatory bowel disease, though some caution is still warranted.

Eubacterium hallii shows a strong literature footprint in inflammatory bowel disease, with substantial central evidence and broader supporting literature.

Parabacteroides distasonis has meaningful literature visibility in crohn's disease, but the current evidence mix suggests a substantial risk of overclaiming.

Parabacteroides distasonis shows a strong literature footprint in crohn's disease, with substantial central evidence and broader supporting literature.

Blautia looks like a credible signal in type 2 diabetes, though some caution is still warranted.

Blautia shows a strong literature footprint in type 2 diabetes, with substantial central evidence and broader supporting literature.

Desulfovibrio looks like a credible signal in colorectal cancer, though some caution is still warranted.

Desulfovibrio shows a strong literature footprint in colorectal cancer, with substantial central evidence and broader supporting literature.

Ruminococcus torques looks like a credible signal in inflammatory bowel disease, though some caution is still warranted.

Ruminococcus torques shows a strong literature footprint in inflammatory bowel disease, with substantial central evidence and broader supporting literature.

Bacteroides vulgatus looks like a credible signal in type 2 diabetes, though some caution is still warranted.

Bacteroides vulgatus shows a strong literature footprint in type 2 diabetes, with substantial central evidence and broader supporting literature.

Propionate production looks like a credible signal in autism, though some caution is still warranted.

Propionate production shows a strong literature footprint in autism, with substantial central evidence and broader supporting literature.

Roseburia looks like a credible signal in obesity, though some caution is still warranted.

Roseburia shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Prevotella looks like a credible signal in crohn's disease, though some caution is still warranted.

Prevotella shows a strong literature footprint in crohn's disease, with substantial central evidence and broader supporting literature.

Streptococcus looks like a credible signal in inflammatory bowel disease, though some caution is still warranted.

Streptococcus shows a strong literature footprint in inflammatory bowel disease, with substantial central evidence and broader supporting literature.

Blautia looks like a credible signal in inflammatory bowel disease, though some caution is still warranted.

Blautia shows a strong literature footprint in inflammatory bowel disease, with substantial central evidence and broader supporting literature.

Prevotella copri looks like a credible signal in inflammatory bowel disease, though some caution is still warranted.

Prevotella copri shows a strong literature footprint in inflammatory bowel disease, with substantial central evidence and broader supporting literature.

Proteobacteria looks like a credible signal in autism, though some caution is still warranted.

Proteobacteria shows a strong literature footprint in autism, with substantial central evidence and broader supporting literature.

Richness looks like a credible signal in crohn's disease, though some caution is still warranted.

Richness shows a strong literature footprint in crohn's disease, with substantial central evidence and broader supporting literature.

Faecalibacterium looks like a credible signal in inflammatory bowel disease, though some caution is still warranted.

Faecalibacterium shows a strong literature footprint in inflammatory bowel disease, with substantial central evidence and broader supporting literature.

Bacteroides ovatus looks like a credible signal in colorectal cancer, though some caution is still warranted.

Bacteroides ovatus shows a strong literature footprint in colorectal cancer, with substantial central evidence and broader supporting literature.

Ruminococcus torques looks like a credible signal in ulcerative colitis, though some caution is still warranted.

Ruminococcus torques shows a strong literature footprint in ulcerative colitis, with substantial central evidence and broader supporting literature.

Streptococcus looks like a credible signal in autism, though some caution is still warranted.

Streptococcus shows a strong literature footprint in autism, with substantial central evidence and broader supporting literature.

Prevotella looks like a credible signal in inflammatory bowel disease, though some caution is still warranted.

Prevotella shows a strong literature footprint in inflammatory bowel disease, with substantial central evidence and broader supporting literature.

Prevotella copri looks like a credible signal in autism, though some caution is still warranted.

Prevotella copri shows a strong literature footprint in autism, with substantial central evidence and broader supporting literature.

Richness looks like a credible signal in inflammatory bowel disease, though some caution is still warranted.

Richness shows a strong literature footprint in inflammatory bowel disease, with substantial central evidence and broader supporting literature.

Roseburia looks like a credible signal in inflammatory bowel disease, though some caution is still warranted.

Roseburia shows a strong literature footprint in inflammatory bowel disease, with substantial central evidence and broader supporting literature.

Akkermansia muciniphila looks like a credible signal in autism, though some caution is still warranted.

Akkermansia muciniphila shows a strong literature footprint in autism, with substantial central evidence and broader supporting literature.

Acetate production has meaningful literature visibility in inflammatory bowel disease, but the current evidence mix suggests a substantial risk of overclaiming.

Acetate production shows a strong literature footprint in inflammatory bowel disease, with substantial central evidence and broader supporting literature.

Clostridioides difficile looks like a credible signal in obesity, though some caution is still warranted.

Clostridioides difficile shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Faecalibacterium looks like a credible signal in crohn's disease, though some caution is still warranted.

Faecalibacterium shows a strong literature footprint in crohn's disease, with substantial central evidence and broader supporting literature.

Coprococcus looks like a credible signal in inflammatory bowel disease, though some caution is still warranted.

Coprococcus shows a strong literature footprint in inflammatory bowel disease, with substantial central evidence and broader supporting literature.

Prevotella has meaningful literature visibility in ulcerative colitis, but the current evidence mix suggests a substantial risk of overclaiming.

Prevotella shows a strong literature footprint in ulcerative colitis, with substantial central evidence and broader supporting literature.

Collinsella aerofaciens looks like a credible signal in type 2 diabetes, though some caution is still warranted.

Collinsella aerofaciens shows a strong literature footprint in type 2 diabetes, with substantial central evidence and broader supporting literature.

Eubacterium hallii looks like a credible signal in type 2 diabetes, though some caution is still warranted.

Eubacterium hallii shows a strong literature footprint in type 2 diabetes, with substantial central evidence and broader supporting literature.

Prevotella looks like a credible signal in autism, though some caution is still warranted.

Prevotella shows a strong literature footprint in autism, with substantial central evidence and broader supporting literature.

Streptococcus looks like a credible signal in crohn's disease, though some caution is still warranted.

Streptococcus shows a strong literature footprint in crohn's disease, with substantial central evidence and broader supporting literature.

Richness has meaningful literature visibility in type 2 diabetes, but the current evidence mix suggests a substantial risk of overclaiming.

Richness shows a strong literature footprint in type 2 diabetes, with substantial central evidence and broader supporting literature.

Bacteroides ovatus has meaningful literature visibility in obesity, but the current evidence mix suggests a substantial risk of overclaiming.

Bacteroides ovatus shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Desulfovibrio is an interesting but still moderate-confidence signal in type 2 diabetes.

Desulfovibrio shows a strong literature footprint in type 2 diabetes, with substantial central evidence and broader supporting literature.

Eubacterium rectale is an interesting but still moderate-confidence signal in type 2 diabetes.

Eubacterium rectale shows a strong literature footprint in type 2 diabetes, with substantial central evidence and broader supporting literature.

Bacteroides uniformis has meaningful literature visibility in ulcerative colitis, but the current evidence mix suggests a substantial risk of overclaiming.

Bacteroides uniformis shows a strong literature footprint in ulcerative colitis, with substantial central evidence and broader supporting literature.

Bacteroides ovatus is an interesting but still moderate-confidence signal in type 2 diabetes.

Bacteroides ovatus shows a strong literature footprint in type 2 diabetes, with substantial central evidence and broader supporting literature.

Roseburia is an interesting but still moderate-confidence signal in crohn's disease.

Roseburia shows a strong literature footprint in crohn's disease, with substantial central evidence and broader supporting literature.

Bacteroides fragilis is an interesting but still moderate-confidence signal in autism.

Bacteroides fragilis shows a strong literature footprint in autism, with substantial central evidence and broader supporting literature.

Bacteroides uniformis is an interesting but still moderate-confidence signal in autism.

Bacteroides uniformis shows a strong literature footprint in autism, with substantial central evidence and broader supporting literature.

Anaerostipes hadrus is an interesting but still moderate-confidence signal in type 2 diabetes.

Anaerostipes hadrus shows a strong literature footprint in type 2 diabetes, with substantial central evidence and broader supporting literature.

Subdoligranulum is an interesting but still moderate-confidence signal in obesity.

Subdoligranulum shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Veillonella is an interesting but still moderate-confidence signal in colorectal cancer.

Veillonella shows a strong literature footprint in colorectal cancer, with substantial central evidence and broader supporting literature.

Alistipes has meaningful literature visibility in inflammatory bowel disease, but the current evidence mix suggests a substantial risk of overclaiming.

Alistipes shows a strong literature footprint in inflammatory bowel disease, with substantial central evidence and broader supporting literature.

Desulfovibrio has meaningful literature visibility in obesity, but the current evidence mix suggests a substantial risk of overclaiming.

Desulfovibrio shows a strong literature footprint in obesity, with substantial central evidence and broader supporting literature.

Coprococcus is an interesting but still moderate-confidence signal in type 2 diabetes.

Coprococcus shows a strong literature footprint in type 2 diabetes, with substantial central evidence and broader supporting literature.

Blautia is an interesting but still moderate-confidence signal in autism.

Blautia shows a strong literature footprint in autism, with substantial central evidence and broader supporting literature.

Richness is an interesting but still moderate-confidence signal in autism.

Richness shows a strong literature footprint in autism, with substantial central evidence and broader supporting literature.

Veillonella is an interesting but still moderate-confidence signal in type 2 diabetes.

Veillonella shows a strong literature footprint in type 2 diabetes, with substantial central evidence and broader supporting literature.

Bacteroides ovatus has meaningful literature visibility in crohn's disease, but the current evidence mix suggests a substantial risk of overclaiming.

Bacteroides ovatus shows a strong literature footprint in crohn's disease, with substantial central evidence and broader supporting literature.

Dialister is an interesting but still moderate-confidence signal in crohn's disease.

Dialister shows a strong literature footprint in crohn's disease, with substantial central evidence and broader supporting literature.

Eubacterium hallii is an interesting but still moderate-confidence signal in autism.

Eubacterium hallii shows a strong literature footprint in autism, with substantial central evidence and broader supporting literature.

Faecalibacterium prausnitzii is an interesting but still moderate-confidence signal in atopic dermatitis.

Faecalibacterium prausnitzii shows a strong literature footprint in atopic dermatitis, with substantial central evidence and broader supporting literature.

Dialister is an interesting but still moderate-confidence signal in type 2 diabetes.

Dialister shows a strong literature footprint in type 2 diabetes, with substantial central evidence and broader supporting literature.

Intestinal permeability looks like a credible signal in type 2 diabetes, though some caution is still warranted.

Intestinal permeability shows a moderate evidence base in type 2 diabetes, with multiple central papers and additional supporting literature.

Staphylococcus epidermidis has meaningful literature visibility in atopic dermatitis, but the current evidence mix suggests a substantial risk of overclaiming.

Staphylococcus epidermidis shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Bile acid metabolism has meaningful literature visibility in obesity, but the current evidence mix suggests a substantial risk of overclaiming.

Bile acid metabolism shows a moderate evidence base in obesity, with multiple central papers and additional supporting literature.

Bile acid metabolism has meaningful literature visibility in colorectal cancer, but the current evidence mix suggests a substantial risk of overclaiming.

Bile acid metabolism shows a moderate evidence base in colorectal cancer, with multiple central papers and additional supporting literature.

Tryptophan metabolism has meaningful literature visibility in autism, but the current evidence mix suggests a substantial risk of overclaiming.

Tryptophan metabolism shows a moderate evidence base in autism, with multiple central papers and additional supporting literature.

Bile acid metabolism has meaningful literature visibility in type 2 diabetes, but the current evidence mix suggests a substantial risk of overclaiming.

Bile acid metabolism shows a moderate evidence base in type 2 diabetes, with multiple central papers and additional supporting literature.

Staphylococcus aureus looks like a credible signal in atopic dermatitis, though some caution is still warranted.

Staphylococcus aureus shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Bile acid metabolism has meaningful literature visibility in crohn's disease, but the current evidence mix suggests a substantial risk of overclaiming.

Bile acid metabolism shows a moderate evidence base in crohn's disease, with multiple central papers and additional supporting literature.

Escherichia coli has meaningful literature visibility in crohn's disease, but the current evidence mix suggests a substantial risk of overclaiming.

Escherichia coli shows a moderate evidence base in crohn's disease, with multiple central papers and additional supporting literature.

Lactobacillus has meaningful literature visibility in obesity, but the current evidence mix suggests a substantial risk of overclaiming.

Lactobacillus shows a moderate evidence base in obesity, with multiple central papers and additional supporting literature.

Clostridioides difficile looks like a credible signal in crohn's disease, though some caution is still warranted.

Clostridioides difficile shows a moderate evidence base in crohn's disease, with multiple central papers and additional supporting literature.

Staphylococcus looks like a credible signal in atopic dermatitis, though some caution is still warranted.

Staphylococcus shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Bacteroides fragilis looks like a credible signal in colorectal cancer, though some caution is still warranted.

Bacteroides fragilis shows a moderate evidence base in colorectal cancer, with multiple central papers and additional supporting literature.

Fusobacterium nucleatum looks like a credible signal in inflammatory bowel disease, though some caution is still warranted.

Fusobacterium nucleatum shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Candida albicans has meaningful literature visibility in inflammatory bowel disease, but the current evidence mix suggests a substantial risk of overclaiming.

Candida albicans shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Clostridioides difficile looks like a credible signal in inflammatory bowel disease, though some caution is still warranted.

Clostridioides difficile shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Bile acid metabolism has meaningful literature visibility in inflammatory bowel disease, but the current evidence mix suggests a substantial risk of overclaiming.

Bile acid metabolism shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Saccharomyces looks like a credible signal in inflammatory bowel disease, though some caution is still warranted.

Saccharomyces shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Lactobacillus has meaningful literature visibility in atopic dermatitis, but the current evidence mix suggests a substantial risk of overclaiming.

Lactobacillus shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Escherichia coli has meaningful literature visibility in inflammatory bowel disease, but the current evidence mix suggests a substantial risk of overclaiming.

Escherichia coli shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Candida albicans has meaningful literature visibility in crohn's disease, but the current evidence mix suggests a substantial risk of overclaiming.

Candida albicans shows a moderate evidence base in crohn's disease, with multiple central papers and additional supporting literature.

Intestinal permeability has meaningful literature visibility in atopic dermatitis, but the current evidence mix suggests a substantial risk of overclaiming.

Intestinal permeability shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Lactobacillus has meaningful literature visibility in type 2 diabetes, but the current evidence mix suggests a substantial risk of overclaiming.

Lactobacillus shows a moderate evidence base in type 2 diabetes, with multiple central papers and additional supporting literature.

Staphylococcus hominis has meaningful literature visibility in atopic dermatitis, but the current evidence mix suggests a substantial risk of overclaiming.

Staphylococcus hominis shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Candida albicans has meaningful literature visibility in atopic dermatitis, but the current evidence mix suggests a substantial risk of overclaiming.

Candida albicans shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Acetate production has meaningful literature visibility in colorectal cancer, but the current evidence mix suggests a substantial risk of overclaiming.

Acetate production shows a moderate evidence base in colorectal cancer, with multiple central papers and additional supporting literature.

Akkermansia muciniphila has meaningful literature visibility in type 2 diabetes, but the current evidence mix suggests a substantial risk of overclaiming.

Akkermansia muciniphila shows a moderate evidence base in type 2 diabetes, with multiple central papers and additional supporting literature.

Roseburia is an interesting but still moderate-confidence signal in type 2 diabetes.

Roseburia shows a moderate evidence base in type 2 diabetes, with multiple central papers and additional supporting literature.

Richness is an interesting but still moderate-confidence signal in obesity.

Richness shows a moderate evidence base in obesity, with multiple central papers and additional supporting literature.

Streptococcus is an interesting but still moderate-confidence signal in colorectal cancer.

Streptococcus shows a moderate evidence base in colorectal cancer, with multiple central papers and additional supporting literature.

Acetate production has meaningful literature visibility in autism, but the current evidence mix suggests a substantial risk of overclaiming.

Acetate production shows a moderate evidence base in autism, with multiple central papers and additional supporting literature.

Lipopolysaccharide biosynthesis has meaningful literature visibility in colorectal cancer, but the current evidence mix suggests a substantial risk of overclaiming.

Lipopolysaccharide biosynthesis shows a moderate evidence base in colorectal cancer, with multiple central papers and additional supporting literature.

Proteobacteria has meaningful literature visibility in atopic dermatitis, but the current evidence mix suggests a substantial risk of overclaiming.

Proteobacteria shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Bifidobacterium has meaningful literature visibility in type 2 diabetes, but the current evidence mix suggests a substantial risk of overclaiming.

Bifidobacterium shows a moderate evidence base in type 2 diabetes, with multiple central papers and additional supporting literature.

Staphylococcus capitis has meaningful literature visibility in atopic dermatitis, but the current evidence mix suggests a substantial risk of overclaiming.

Staphylococcus capitis shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Tryptophan metabolism is an interesting but still moderate-confidence signal in atopic dermatitis.

Tryptophan metabolism shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Propionate production has meaningful literature visibility in obesity, but the current evidence mix suggests a substantial risk of overclaiming.

Propionate production shows a moderate evidence base in obesity, with multiple central papers and additional supporting literature.

Cutibacterium acnes is an interesting but still moderate-confidence signal in atopic dermatitis.

Cutibacterium acnes shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Lipopolysaccharide biosynthesis has meaningful literature visibility in crohn's disease, but the current evidence mix suggests a substantial risk of overclaiming.

Lipopolysaccharide biosynthesis shows a moderate evidence base in crohn's disease, with multiple central papers and additional supporting literature.

Butyrate production is an interesting but still moderate-confidence signal in autism.

Butyrate production shows a moderate evidence base in autism, with multiple central papers and additional supporting literature.

Bifidobacterium is an interesting but still moderate-confidence signal in autism.

Bifidobacterium shows a moderate evidence base in autism, with multiple central papers and additional supporting literature.

Streptococcus is an interesting but still moderate-confidence signal in atopic dermatitis.

Streptococcus shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Malassezia has meaningful literature visibility in atopic dermatitis, but the current evidence mix suggests a substantial risk of overclaiming.

Malassezia has a broader but less central evidence footprint in atopic dermatitis, with support coming from indirect, review, or preclinical literature.

Staphylococcus haemolyticus has meaningful literature visibility in atopic dermatitis, but the current evidence mix suggests a substantial risk of overclaiming.

Staphylococcus haemolyticus shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Acetate production has meaningful literature visibility in type 2 diabetes, but the current evidence mix suggests a substantial risk of overclaiming.

Acetate production shows a moderate evidence base in type 2 diabetes, with multiple central papers and additional supporting literature.

Akkermansia muciniphila has meaningful literature visibility in obesity, but the current evidence mix suggests a substantial risk of overclaiming.

Akkermansia muciniphila shows a moderate evidence base in obesity, with multiple central papers and additional supporting literature.

Propionate production is an interesting but still moderate-confidence signal in inflammatory bowel disease.

Propionate production shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Candida is an interesting but still moderate-confidence signal in inflammatory bowel disease.

Candida shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Cutibacterium is an interesting but still moderate-confidence signal in atopic dermatitis.

Cutibacterium shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Desulfovibrio has meaningful literature visibility in ulcerative colitis, but the current evidence mix suggests a substantial risk of overclaiming.

Desulfovibrio shows a moderate evidence base in ulcerative colitis, with multiple central papers and additional supporting literature.

Acetate production has meaningful literature visibility in crohn's disease, but the current evidence mix suggests a substantial risk of overclaiming.

Acetate production shows a moderate evidence base in crohn's disease, with multiple central papers and additional supporting literature.

Parabacteroides distasonis has meaningful literature visibility in inflammatory bowel disease, but the current evidence mix suggests a substantial risk of overclaiming.

Parabacteroides distasonis shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Tryptophan metabolism has meaningful literature visibility in inflammatory bowel disease, but the current evidence mix suggests a substantial risk of overclaiming.

Tryptophan metabolism shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Butyrate production has meaningful literature visibility in atopic dermatitis, but the current evidence mix suggests a substantial risk of overclaiming.

Butyrate production shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Lipopolysaccharide biosynthesis has meaningful literature visibility in inflammatory bowel disease, but the current evidence mix suggests a substantial risk of overclaiming.

Lipopolysaccharide biosynthesis shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Desulfovibrio has meaningful literature visibility in crohn's disease, but the current evidence mix suggests a substantial risk of overclaiming.

Desulfovibrio shows a moderate evidence base in crohn's disease, with multiple central papers and additional supporting literature.

Propionate production has meaningful literature visibility in crohn's disease, but the current evidence mix suggests a substantial risk of overclaiming.

Propionate production shows a moderate evidence base in crohn's disease, with multiple central papers and additional supporting literature.

Bifidobacterium has meaningful literature visibility in inflammatory bowel disease, but the current evidence mix suggests a substantial risk of overclaiming.

Bifidobacterium shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Candida has meaningful literature visibility in crohn's disease, but the current evidence mix suggests a substantial risk of overclaiming.

Candida shows a moderate evidence base in crohn's disease, with multiple central papers and additional supporting literature.

Tryptophan metabolism has meaningful literature visibility in crohn's disease, but the current evidence mix suggests a substantial risk of overclaiming.

Tryptophan metabolism shows a moderate evidence base in crohn's disease, with multiple central papers and additional supporting literature.

Desulfovibrio has meaningful literature visibility in inflammatory bowel disease, but the current evidence mix suggests a substantial risk of overclaiming.

Desulfovibrio shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Propionate production has meaningful literature visibility in type 2 diabetes, but the current evidence mix suggests a substantial risk of overclaiming.

Propionate production shows a moderate evidence base in type 2 diabetes, with multiple central papers and additional supporting literature.

Candida has meaningful literature visibility in atopic dermatitis, but the current evidence mix suggests a substantial risk of overclaiming.

Candida has a broader but less central evidence footprint in atopic dermatitis, with support coming from indirect, review, or preclinical literature.

Staphylococcus has meaningful literature visibility in inflammatory bowel disease, but the current evidence mix suggests a substantial risk of overclaiming.

Staphylococcus shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Lactobacillus has meaningful literature visibility in inflammatory bowel disease, but the current evidence mix suggests a substantial risk of overclaiming.

Lactobacillus shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Lipopolysaccharide biosynthesis has meaningful literature visibility in ulcerative colitis, but the current evidence mix suggests a substantial risk of overclaiming.

Lipopolysaccharide biosynthesis shows a moderate evidence base in ulcerative colitis, with multiple central papers and additional supporting literature.

Saccharomyces has meaningful literature visibility in obesity, but the current evidence mix suggests a substantial risk of overclaiming.

Saccharomyces has a broader but less central evidence footprint in obesity, with support coming from indirect, review, or preclinical literature.

Bacteroides uniformis has meaningful literature visibility in crohn's disease, but the current evidence mix suggests a substantial risk of overclaiming.

Bacteroides uniformis shows a moderate evidence base in crohn's disease, with multiple central papers and additional supporting literature.

Bilophila wadsworthia is an interesting but still moderate-confidence signal in crohn's disease.

Bilophila wadsworthia shows a moderate evidence base in crohn's disease, with multiple central papers and additional supporting literature.

Corynebacterium has meaningful literature visibility in atopic dermatitis, but the current evidence mix suggests a substantial risk of overclaiming.

Corynebacterium shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Corynebacterium tuberculostearicum is an interesting but still moderate-confidence signal in atopic dermatitis.

Corynebacterium tuberculostearicum shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Bacteroides ovatus has meaningful literature visibility in inflammatory bowel disease, but the current evidence mix suggests a substantial risk of overclaiming.

Bacteroides ovatus shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Anaerostipes hadrus is an interesting but still moderate-confidence signal in inflammatory bowel disease.

Anaerostipes hadrus shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Shannon diversity is an interesting but still moderate-confidence signal in autism.

Shannon diversity shows a moderate evidence base in autism, with multiple central papers and additional supporting literature.

Shannon diversity has meaningful literature visibility in atopic dermatitis, but the current evidence mix suggests a substantial risk of overclaiming.

Shannon diversity shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Bilophila wadsworthia is an interesting but still moderate-confidence signal in inflammatory bowel disease.

Bilophila wadsworthia shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Flavonifractor plautii is an interesting but still moderate-confidence signal in colorectal cancer.

Flavonifractor plautii shows a moderate evidence base in colorectal cancer, with multiple central papers and additional supporting literature.

Subdoligranulum is an interesting but still moderate-confidence signal in type 2 diabetes.

Subdoligranulum shows a moderate evidence base in type 2 diabetes, with multiple central papers and additional supporting literature.

Lipopolysaccharide biosynthesis has meaningful literature visibility in atopic dermatitis, but the current evidence mix suggests a substantial risk of overclaiming.

Lipopolysaccharide biosynthesis shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Subdoligranulum is an interesting but still moderate-confidence signal in crohn's disease.

Subdoligranulum shows a moderate evidence base in crohn's disease, with multiple central papers and additional supporting literature.

Mucin degradation has meaningful literature visibility in atopic dermatitis, but the current evidence mix suggests a substantial risk of overclaiming.

Mucin degradation shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Richness has meaningful literature visibility in atopic dermatitis, but the current evidence mix suggests a substantial risk of overclaiming.

Richness shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Candida is an interesting but still moderate-confidence signal in autism.

Candida shows a moderate evidence base in autism, with multiple central papers and additional supporting literature.

Coprococcus is an interesting but still moderate-confidence signal in autism.

Coprococcus shows a moderate evidence base in autism, with multiple central papers and additional supporting literature.

Dialister is an interesting but still moderate-confidence signal in inflammatory bowel disease.

Dialister shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Collinsella aerofaciens is an interesting but still moderate-confidence signal in inflammatory bowel disease.

Collinsella aerofaciens shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Bacteroides uniformis has meaningful literature visibility in inflammatory bowel disease, but the current evidence mix suggests a substantial risk of overclaiming.

Bacteroides uniformis shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Saccharomyces has meaningful literature visibility in autism, but the current evidence mix suggests a substantial risk of overclaiming.

Saccharomyces shows a moderate evidence base in autism, with multiple central papers and additional supporting literature.

Bilophila wadsworthia has meaningful literature visibility in colorectal cancer, but the current evidence mix suggests a substantial risk of overclaiming.

Bilophila wadsworthia shows a moderate evidence base in colorectal cancer, with multiple central papers and additional supporting literature.

Alistipes has meaningful literature visibility in autism, but the current evidence mix suggests a substantial risk of overclaiming.

Alistipes shows a moderate evidence base in autism, with multiple central papers and additional supporting literature.

Malassezia is an interesting but still moderate-confidence signal in inflammatory bowel disease.

Malassezia shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Saccharomyces has meaningful literature visibility in atopic dermatitis, but the current evidence mix suggests a substantial risk of overclaiming.

Saccharomyces has a broader but less central evidence footprint in atopic dermatitis, with support coming from indirect, review, or preclinical literature.

Subdoligranulum is an interesting but still moderate-confidence signal in inflammatory bowel disease.

Subdoligranulum shows a moderate evidence base in inflammatory bowel disease, with multiple central papers and additional supporting literature.

Bilophila wadsworthia has meaningful literature visibility in ulcerative colitis, but the current evidence mix suggests a substantial risk of overclaiming.

Bilophila wadsworthia shows a moderate evidence base in ulcerative colitis, with multiple central papers and additional supporting literature.

Roseomonas has meaningful literature visibility in atopic dermatitis, but the current evidence mix suggests a substantial risk of overclaiming.

Roseomonas has a broader but less central evidence footprint in atopic dermatitis, with support coming from indirect, review, or preclinical literature.

Dialister is an interesting but still moderate-confidence signal in autism.

Dialister shows a moderate evidence base in autism, with multiple central papers and additional supporting literature.

Dialister is an interesting but still moderate-confidence signal in ulcerative colitis.

Dialister shows a moderate evidence base in ulcerative colitis, with multiple central papers and additional supporting literature.

Acinetobacter is an interesting but still moderate-confidence signal in atopic dermatitis.

Acinetobacter shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Veillonella is an interesting but still moderate-confidence signal in atopic dermatitis.

Veillonella shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

Anaerostipes hadrus is an interesting but still moderate-confidence signal in autism.

Anaerostipes hadrus currently has limited structured evidence in autism within this first-pass atlas build.

Flavonifractor plautii has meaningful literature visibility in inflammatory bowel disease, but the current evidence mix suggests a substantial risk of overclaiming.

Flavonifractor plautii has a broader but less central evidence footprint in inflammatory bowel disease, with support coming from indirect, review, or preclinical literature.

Micrococcus has meaningful literature visibility in atopic dermatitis, but the current evidence mix suggests a substantial risk of overclaiming.

Micrococcus has a broader but less central evidence footprint in atopic dermatitis, with support coming from indirect, review, or preclinical literature.

Coprococcus is an interesting but still moderate-confidence signal in atopic dermatitis.

Coprococcus currently has limited structured evidence in atopic dermatitis within this first-pass atlas build.

Staphylococcus has meaningful literature visibility in autism, but the current evidence mix suggests a substantial risk of overclaiming.

Staphylococcus has a broader but less central evidence footprint in autism, with support coming from indirect, review, or preclinical literature.

Anaerostipes hadrus is an interesting but still moderate-confidence signal in atopic dermatitis.

Anaerostipes hadrus currently has limited structured evidence in atopic dermatitis within this first-pass atlas build.

Evenness has meaningful literature visibility in atopic dermatitis, but the current evidence mix suggests a substantial risk of overclaiming.

Evenness has a broader but less central evidence footprint in atopic dermatitis, with support coming from indirect, review, or preclinical literature.

Subdoligranulum is an interesting but still moderate-confidence signal in autism.

Subdoligranulum currently has limited structured evidence in autism within this first-pass atlas build.

Debaryomyces is an interesting but still moderate-confidence signal in atopic dermatitis.

Debaryomyces currently has limited structured evidence in atopic dermatitis within this first-pass atlas build.

Dolosigranulum is an interesting but still moderate-confidence signal in atopic dermatitis.

Dolosigranulum currently has limited structured evidence in atopic dermatitis within this first-pass atlas build.

Malassezia is an interesting but still moderate-confidence signal in autism.

Malassezia currently has limited structured evidence in autism within this first-pass atlas build.